These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 35507486)
1. Baricitinib in Alopecia Areata. Messenger A; Harries M N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486 [No Abstract] [Full Text] [Related]
2. Oral Baricitinib Restores Hair Loss in Alopecia Areata. Slomski A JAMA; 2022 Jun; 327(24):2386. PubMed ID: 35762995 [No Abstract] [Full Text] [Related]
3. Successful treatment of alopecia areata-associated trachyonychia with baricitinib. Rózsa P; Degovics D; Baltás E; Gyulai R; Kemény L Int J Dermatol; 2024 Aug; 63(8):1089-1090. PubMed ID: 38514896 [No Abstract] [Full Text] [Related]
4. Two Phase 3 Trials of Baricitinib for Alopecia Areata. King B; Ohyama M; Kwon O; Zlotogorski A; Ko J; Mesinkovska NA; Hordinsky M; Dutronc Y; Wu WS; McCollam J; Chiasserini C; Yu G; Stanley S; Holzwarth K; DeLozier AM; Sinclair R; N Engl J Med; 2022 May; 386(18):1687-1699. PubMed ID: 35334197 [TBL] [Abstract][Full Text] [Related]
5. Treatment of moderate-to-severe alopecia areata in patients over the age of 65 years with baricitinib. Tang GT; Triwongwaranat D; Sinclair R; Joseph S; Eisman S; Rathnayake D; Varathan V; Trindade de Carvalho L; Bhoyrul B Clin Exp Dermatol; 2024 Jul; 49(8):875-878. PubMed ID: 38270233 [TBL] [Abstract][Full Text] [Related]
6. Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients. Moreno-Vílchez C; Bonfill-Ortí M; Bauer-Alonso A; Notario J; Figueras-Nart I J Am Acad Dermatol; 2024 May; 90(5):1059-1061. PubMed ID: 38246562 [No Abstract] [Full Text] [Related]
7. Exploring Janus kinase inhibitors for alopecia areata: a comprehensive review. Bushwereb R; Srivastava G Ital J Dermatol Venerol; 2024 Aug; 159(4):380-389. PubMed ID: 38780910 [TBL] [Abstract][Full Text] [Related]
8. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation. Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867 [No Abstract] [Full Text] [Related]
16. Baricitinib: A Review in Severe Alopecia Areata. Fung S; Shirley M Am J Clin Dermatol; 2023 Jul; 24(4):661-668. PubMed ID: 37326792 [TBL] [Abstract][Full Text] [Related]
17. Baricitinib as a treatment for myasthenia gravis: a case report. Iguchi M; Honjo J; Yamamoto T; Kanai K Neuromuscul Disord; 2024 Aug; 41():56-58. PubMed ID: 38954991 [TBL] [Abstract][Full Text] [Related]
18. Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib. De la Torre-Gomar FJ; Velasco-Amador JP; Prados-Carmona Á; Ruiz-Villaverde R J Dermatolog Treat; 2024 Dec; 35(1):2304630. PubMed ID: 38240097 [No Abstract] [Full Text] [Related]
19. Treatment of alopecia areata of the beard with baricitinib. Moussa A; Eisman S; Sinclair RD; Bhoyrul B J Am Acad Dermatol; 2023 Apr; 88(4):948-950. PubMed ID: 36427662 [No Abstract] [Full Text] [Related]
20. Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report. Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y J Dermatol; 2021 Sep; 48(9):e472-e473. PubMed ID: 34151450 [No Abstract] [Full Text] [Related] [Next] [New Search]